All three major indexes are moving higher on both the day and week, as crude and yields pull back

HP heads into Q2 earnings results with AI PC demand and gaming products expected to support revenue growth.

For decades, supplement research has not supported cartilage regeneration. A randomized, placebo-controlled study in Pharmaceutical Research documented measurable cartilage regeneration biomarkers at 90 days, a breakthrough for the category* (Vaidya 2025) Three published human studies covering more than 1,700 participants anchor the Cartigenix HP® research profile In the studies, participants showed an average 67% reduction in pain scores and an average 50% increase in walking distance within 90 days, with noticeable improvements as early as 15 days SCOTTSDALE, AZ, May 22, 2026 (GLOBE NEWSWIRE) -- Cartilage regeneration has long been unsupported in peer-reviewed supplement literature, a ceiling reflected in decades of clinical research on the category's dominant ingredients, glucosamine and chondroitin.

On May 21, 2026, HP Inc (HPQ) shares rose 3.9%, bringing the current price to $21.90. Over the past 52 weeks, the stock has experienced a high of $29.55 and a l

Beyond analysts' top-and-bottom-line estimates for HP (HPQ), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2026.

HP Inc (NYSE:HPQ) is expected to report a solid fiscal second quarter later this month, though Bank of America analysts say investors are likely to focus more closely on the company's outlook for fiscal 2026 amid concerns over PC demand, rising memory costs and leadership uncertainty. Bank of America maintained its ‘Underperform' rating and $16 price target on the stock ahead of the report.

HP Inc (NYSE:HPQ) is expected to report a solid fiscal second quarter later this month, though Bank of America analysts say investors are likely to focus...

PALO ALTO, Calif, May 19, 2026 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.3000 per share on the company's common stock.

On May 11, 2026, HP Inc (HPQ) shares fell 4.5% to a current price of $21.67. This decline comes amid a 52-week range of $17.56 to $29.55, indicating volatility

HP (HPQ) closed the most recent trading day at $21.67, moving 4.45% from the previous trading session.